Arrhythmia Unit, Department of Cardiology, Hospital Universitario Sant Pau, Barcelona, Spain.
Arrhythmia Unit, Department of Cardiology, Universitäts Herzzentrum Freiburg-Bad Krozingen, Bad Krozingen, Germany.
J Cardiovasc Electrophysiol. 2021 Jun;32(6):1584-1593. doi: 10.1111/jce.15013. Epub 2021 May 5.
The assessment of noninvasive markers of left atrial (LA) low-voltage substrate (LVS) enables the identification of atrial fibrillation (AF) patients at risk for arrhythmia recurrence after pulmonary vein isolation (PVI).
In this prospective multicenter study, 292 consecutive AF patients (72% male, 62 ± 11 years, 65% persistent AF) underwent high-density LA voltage mapping in sinus rhythm. LA-LVS (<0.5 mV) was considered as significant at 2 cm or above. Preprocedural clinical electrocardiogram and echocardiographic data were assessed to identify predictors of LA-LVS. The role of the identified LA-LVS markers in predicting 1-year arrhythmia freedom after PVI was assessed in 245 patients.
Significant LA-LVS was identified in 123 (42%) patients. The amplified sinus P-wave duration (APWD) best predicted LA-LVS, with a 148-ms value providing the best-balanced sensitivity (0.81) and specificity (0.88). An APWD over 160 ms was associated with LA-LVS in 96% of patients, whereas an APWD under 145 ms in 15%. Remaining gray zones improved their accuracy by introduction of systolic pulmonary artery pressure (sPAP) of 35 mmHg or above, age, and sex. According to COX regression, the risk of arrhythmia recurrence 12 months following PVI was twofold and threefold higher in patients with APWD 145-160 and over 160 ms, compared to APWD under 145 ms. Integration of pulmonary hypertension further improved the outcome prediction in the intermediate APWD group: Patients with APWD 145-160 ms and normal sPAP had similar outcome than patients with APWD under 145 ms (hazard ratio [HR] 1.62, p = .14), whereas high sPAP implied worse outcome (HR 2.56, p < .001).
The APWD identifies LA-LVS and risk for arrhythmia recurrence after PVI. Our prediction model becomes optimized by means of integration of the pulmonary artery pressure.
评估左心房(LA)低电压基质(LVS)的无创标志物可识别肺静脉隔离(PVI)后心律失常复发风险的房颤(AF)患者。
在这项前瞻性多中心研究中,292 例连续 AF 患者(72%为男性,62±11 岁,65%为持续性 AF)在窦性心律下接受高密度 LA 电压图描记术。LA-LVS(<0.5 mV)在 2 cm 或以上被认为是显著的。评估术前临床心电图和超声心动图数据,以确定 LA-LVS 的预测因子。在 245 例患者中评估确定的 LA-LVS 标志物在预测 PVI 后 1 年无心律失常的作用。
在 123 例(42%)患者中发现显著的 LA-LVS。放大的窦房结 P 波持续时间(APWD)可最佳预测 LA-LVS,148 ms 值提供最佳平衡的敏感性(0.81)和特异性(0.88)。APWD 超过 160 ms 与 96%的患者的 LA-LVS 相关,而 APWD 低于 145 ms 与 15%的患者相关。通过引入 35 mmHg 或以上的收缩期肺动脉压(sPAP)、年龄和性别,其余的灰色区域提高了其准确性。根据 COX 回归,与 APWD<145 ms 的患者相比,APWD 在 145-160 和超过 160 ms 的患者,PVI 后 12 个月心律失常复发的风险增加了两倍和三倍。肺高压的整合进一步改善了中间 APWD 组的预后预测:APWD 在 145-160 ms 且 sPAP 正常的患者与 APWD<145 ms 的患者的预后相似(风险比[HR]1.62,p=0.14),而高 sPAP 则提示预后更差(HR 2.56,p<0.001)。
APWD 可识别 PVI 后 LA-LVS 和心律失常复发的风险。通过整合肺动脉压,我们的预测模型得到了优化。